| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACTN4
|
actinin, alpha 4
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
CD38
|
CD38 molecule
|
|
CD82
|
CD82 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A4
|
collagen, type IV, alpha 4
|
|
COMT
|
catechol-O-methyltransferase
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
DRD2
|
dopamine receptor D2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
FN1
|
fibronectin 1
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRA4
|
gamma-aminobutyric acid (GABA) A receptor, alpha 4
|
|
GABRE
|
gamma-aminobutyric acid (GABA) A receptor, epsilon
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
IGBP1
|
immunoglobulin (CD79A) binding protein 1
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
KPNA1
|
karyopherin alpha 1 (importin alpha 5)
|
|
KPNA4
|
karyopherin alpha 4 (importin alpha 3)
|
|
LAMA1
|
laminin, alpha 1
|
|
LAMA4
|
laminin, alpha 4
|
|
LAMA5
|
laminin, alpha 5
|
|
LAMB2
|
laminin, beta 2 (laminin S)
|
|
LCMT1
|
leucine carboxyl methyltransferase 1
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAPT
|
microtubule-associated protein tau
|
|
MIR223
|
microRNA 223
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PDCD5
|
programmed cell death 5
|
|
PPME1
|
protein phosphatase methylesterase 1
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PPP4C
|
protein phosphatase 4, catalytic subunit
|
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4
|
|
PRKCA
|
protein kinase C, alpha
|
|
PSMA4
|
proteasome (prosome, macropain) subunit, alpha type, 4
|
|
PSMA7
|
proteasome (prosome, macropain) subunit, alpha type, 7
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PXN
|
paxillin
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
TIPRL
|
TOR signaling pathway regulator
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TP53
|
tumor protein p53
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VWF
|
von Willebrand factor
|
